GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.8036 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.9598 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, TRPV1 |
11.7963 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
11.4715 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, F10, F2, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, MIF, SRC, TNKS, TNKS2, TRPV1, XDH |
9.37523 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GBA2, MIF, PIM1, TYR, XDH |
9.17119 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, SRC, TYR |
8.50762 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.50762 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F2, F3, FLT3, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
7.94374 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F2, F3, FLT3, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
7.93018 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, NR3C1, SRC, TRPV1, TYR |
7.72221 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.44446 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, EGFR, F2, KDR, MIF, SRC, TNKS, TNKS2, TRPV1 |
7.26726 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, NR3C1, SRC, TRPV1, TYR |
6.95128 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
6.88459 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, SRC, TRPV1, TYR |
6.7373 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, PIM1, SRC, XDH |
6.63854 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, EGFR, ERBB2, F10, F2, F3, FLT3, KDR, MET, MIF, PTPN1, SRC, XDH |
6.56737 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.54805 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, F10, F2, F3, FLT3, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
6.53661 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, NR3C1, SRC, TRPV1 |
6.48137 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
6.44459 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, TRPV1 |
6.09555 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, SRC, TYR |
6.09555 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.09555 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.09423 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, FABP3, FABP4, FUT7, GBA2, MET, MIF |
5.92063 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, NR3C1, SRC, TRPV1, TYR |
5.92063 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, NR3C1, SRC, TRPV1 |
5.80688 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.80688 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, ESR1, F2, F3, FLT3, IGF1R, KDR, MIF, MMP12, PIM1 |
5.65757 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MIF, SRC |
5.60143 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.59612 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F10, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
5.49112 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F10, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
5.37772 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
5.37772 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MIF, SRC |
5.29817 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, F10, F2, F3, FLT3, IGF1R, KDR, MET, MIF, PTPN1, SRC, XDH |
5.24123 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, PIM1, PTPN1, SRC, TRPV1, XDH |
5.18284 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, F10, F2, F3, FABP4, FLT3, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
5.15778 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA3, CA9, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, NR3C1, SRC, TRPV1 |
5.12944 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MIF, PIM1, SRC, TNKS2, TYR |
5.12523 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.11856 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, TRPV1 |
4.95061 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, F10, F2, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MIF, MMP12, NR3C1, PTPN1, SRC, TRPV1, TYR |
4.92584 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, F2, KDR, SRC, TRPV1 |
4.92306 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MIF, SRC |
4.91276 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF |
4.9032 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
4.89753 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F2, F3, IGF1R, KDR, MET, MIF, MMP12, PTPN1, SRC, TRPV1 |
4.8679 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, SRC |
4.84022 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, F10, F2, F3, FABP4, HSD11B2, HSD17B2, IGF1R, MET, MMP12, PIM1, SRC, TNKS2, TRPV1, TYR |
4.76745 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, IGF1R, KDR, MET, MIF, PIM1, PTPN1, SRC, TRPV1, XDH |
4.72554 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
4.71804 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
4.69268 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, IGF1R, KDR, MIF, PIM1, PTPN1, SRC, TRPV1, XDH |
4.64268 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, ALOX12, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
4.62004 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, NR3C1, SRC, TRPV1 |
4.61973 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
4.56376 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, GBA2, TYR |
4.40398 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38318 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, ERBB2, F2 |
4.3429 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FLT3, GBA2, HSD11B1, HSD17B2, KDR, PIM1, SRC, TYR |
4.33371 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, PIM1, PTPN1, SRC |
4.33371 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
4.2564 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.24617 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.2255 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.20287 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, MIF, PIM1, SRC, TYR |
4.18463 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, KDR, MET, MIF, SRC |
4.18463 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
4.15739 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, NR3C1, SRC, TRPV1 |
4.11782 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
4.11782 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
4.06831 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.97842 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, EGFR, KDR, NR3C1, SRC, TRPV1 |
3.97737 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, PIM1, PTPN1, SRC |
3.90437 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F10, F3, MET, SRC, XDH |
3.89526 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, MIF, SRC, TNKS, TNKS2, TRPV1 |
3.89526 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, KDR, MIF, PTPN1, SRC, XDH |
3.85244 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, KDR, MIF, PTPN1, SRC, XDH |
3.85244 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.80444 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, NR3C1, SRC |
3.79281 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, F10, F2, F3, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
3.77555 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F10, F3, MET, SRC |
3.76289 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MIF, PIM1, PTPN1, SRC |
3.73602 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, ALOX12, AXL, BCL2, CA2, CACNA1C, CDK6, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, KDR, MET, MIF, MMP12, PIM1, SRC, TNKS2, TRPV1, XDH |
3.72411 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1, SRC |
3.72411 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
3.72411 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
3.67775 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F10, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, PTPN1, SRC, TNKS, TNKS2, XDH |
3.67186 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.6391 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
3.6391 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.6391 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, F10, F2, FLT3, IGF1R, KDR, MET, SRC, TNKS |
3.63749 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
3.6262 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH |
3.58428 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, BCL2, CDK6, CYP19A1, EGFR, ERBB2, ESR1, ESR2, F2, IGF1R, MET, MIF, MMP12, PTPN1, SRC, XDH |
3.543 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.51831 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, SRC |
3.42565 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.35675 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, SRC, TRPV1 |
3.31696 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, NR3C1, PTPN1, SRC, TRPV1 |
3.31271 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, FABP4, MET, TRPV1 |
3.3117 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, ALOX12, MET, TRPV1 |
3.3036 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.26141 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.17723 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.16164 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FLT3, KDR, MIF, PTPN1, SRC, XDH |
3.10969 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, SRC |
3.09388 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.03838 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, SRC, TNKS, TNKS2, TRPV1 |
3.03477 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF |
2.96882 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, MIF |
2.96067 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1 |
2.94401 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, EGFR, ERBB2, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.91285 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CA3, CYP1A1, CYP1B1, KDR, SRC |
2.91051 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82848 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, ALOX12, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, F2, F3, KDR, MET, MIF, MMP12, PIM1, SRC, TRPV1 |
2.81624 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.81624 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.81624 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.81624 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.81624 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, F2, TNKS, TNKS2 |
2.80834 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, EGFR, ESR1, F2, F3, FABP4, KDR, MET, MIF, MMP12 |
2.7988 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.75957 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.73505 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, MET, MIF, PTPN1, SRC, TNKS, XDH |
2.71752 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HSD11B2, SRC, TRPV1, TYR |
2.71439 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.70014 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, F2, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.69772 |
[BP] GO:0030307 |
positive regulation of cell growth
|
ALOX12, BCL2, CSNK2A1, EGFR, ERBB2, F2 |
2.69247 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, F2, F3, FLT3, MIF, PTPN1, SRC, TNKS, XDH |
2.66419 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, BCL2, EGFR, F10, F3, IGF1R, KDR, MET, SRC |
2.64806 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, F2, FLT3, MIF, PTPN1, SRC, TNKS |
2.64061 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, TYR |
2.64061 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, EGFR, ERBB2, F2, MIF, MMP12, SRC, TRPV1 |
2.63084 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.6267 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, IGF1R, MIF, PTPN1, SRC |
2.6248 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.61623 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.61623 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, F2, F3, FLT3, IGF1R, KDR, MET, MIF, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
2.58863 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, SRC |
2.58473 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
2.575 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, F2, TRPV1, XDH |
2.56689 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, BCL2, EGFR, F10, F3, IGF1R, KDR, MET, SRC |
2.56362 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.55606 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, CDK6, CYP19A1, EGFR, ESR1, F2, F3, FABP4, IGF1R, MET, MIF, MMP12, PTPN1, SRC, XDH |
2.55606 |
[BP] GO:0045927 |
positive regulation of growth
|
ALOX12, BCL2, CSNK2A1, EGFR, ERBB2, F2, PIM1 |
2.54692 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, SRC |
2.50661 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, EGFR, ERBB2, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.49719 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, GBA2, MMP12, SRC, XDH |
2.49391 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.49284 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, BCL2, EGFR, F10, F3, IGF1R, KDR, MET, SRC |
2.488 |
[BP] GO:0048146 |
positive regulation of fibroblast proliferation
|
CDK6, EGFR, ESR1, MIF |
2.47036 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.47036 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, MIF, PTPN1, SRC |
2.47036 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.47036 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, F2, FABP4, FLT3, IGF1R, MIF, PTPN1, SRC, TNKS |
2.46369 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.46369 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.46369 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, SRC |
2.46369 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46369 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46369 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, MIF |
2.46174 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45586 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, ESRRB, F2, FABP4, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.45586 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, ALOX12, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, KDR, MIF, PIM1, SRC, TNKS2, TRPV1, XDH |
2.41352 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, BCL2, EGFR, F10, F3, IGF1R, KDR, MET, SRC |
2.40671 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, ERBB2, KDR, MIF, PTPN1, SRC |
2.4016 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, MIF, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
2.39256 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F2, F3, FABP4, KDR, MET, MIF |
2.36009 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, MIF, MMP12, SRC, TRPV1 |
2.36009 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PTPN1, SRC |
2.34699 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.34185 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.34 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.34 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, CDC25B, EGFR, ERBB2, F2, FABP4, FLT3, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.32382 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.31668 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, IGF1R, MIF, PTPN1, SRC, TNKS, XDH |
2.30788 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29216 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, F10, F2, F3, MET, XDH |
2.24002 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23614 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F2, F3, FABP4, FLT3, IGF1R, MET, MIF, PIM1, PTPN1, SRC, TNKS, TRPV1, XDH |
2.23509 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.22311 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET |
2.22311 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.22311 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22311 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22311 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HSD11B2, SRC, TRPV1, TYR |
2.22177 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CYP19A1, ERBB2, MIF, MMP12 |
2.21732 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, ALOX12, BCL2, CSNK2A1, EGFR, ERBB2, ESR2, F2, PIM1, TNKS2 |
2.21732 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20202 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.20117 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, NR3C1, SRC, TNKS, TNKS2, TRPV1 |
2.20015 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, EGFR, ERBB2, ESR1, F10, F2, F3, FLT3, FUT7, GBA2, IGF1R, KDR, MET, MMP12, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
2.16949 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, F2, F3, FLT3, KDR, MIF, PTPN1, SRC, XDH |
2.14042 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, TRPV1 |
2.14042 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.13382 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, EGFR, ERBB2, F2, MIF, MMP12, PTPN1, SRC |
2.12774 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
2.12136 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, PTPN1, SRC, XDH |
2.11868 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.11868 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.11868 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, PTPN1, SRC, XDH |
2.11007 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, F2, FLT3, MIF, PTPN1, SRC |
2.10288 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.08741 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.07821 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4 |
2.07595 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, FABP3, TRPV1 |
2.06778 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.0576 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.0576 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.0576 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.0576 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.0576 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.0576 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, KDR, MET, MMP12, NR3C1, SRC, TNKS, TNKS2 |
2.05187 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.05018 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.04547 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, MIF |
2.04169 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, F2, MIF, MMP12, PTPN1, SRC, TRPV1 |
2.02573 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, MIF |
2.01224 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, ERBB2, F3, KDR, MMP12, XDH |
2.01224 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.00853 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, F2, FABP4, FLT3, IGF1R, MIF, PTPN1, SRC |
2.00853 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, EGFR, ESR1, F10, F2, FABP3, MIF, MMP12, SRC, TNKS, TNKS2, TRPV1, XDH |
2.00605 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, EGFR, HSD11B2, SRC, TRPV1, TYR |
2.00274 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, MIF, PTPN1, SRC |
2.00148 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, F10, F2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MIF, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
4.33371 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX12, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, F10, F2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR |
2.59541 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, F10, F2, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
2.57323 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.39756 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.39636 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX12, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, ESR1, F10, F2, F3, FLT3, GBA2, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TRPV1 |
2.35256 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, F10, F2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, PTPN1, SRC, TRPV1, TYR |
2.00148 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.0431 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, PIM1, PTPN1, TNKS, TYR, XDH |
15.9121 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, F10, F2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
13.1969 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.9239 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
11.7963 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5107 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.44646 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F2, MMP12, NR3C1, PIM1, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
7.21836 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, PTPN1, TNKS |
6.88459 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F2, MMP12, NR3C1, PIM1, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
6.88459 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
6.8667 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.72557 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1 |
6.48137 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, TRPV1 |
6.35647 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
6.05409 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.38962 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.28705 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.12944 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.05936 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.32678 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.00208 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, NR3C1, TRPV1 |
3.94607 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.76289 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CDK6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, NR3C1, TRPV1 |
3.70369 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1 |
3.51831 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
3.48506 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.45279 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.33376 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, NR3C1, TRPV1 |
3.31222 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TRPV1 |
3.30307 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.30307 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.30307 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.29497 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.12376 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, SRC, XDH |
3.10404 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
2.95915 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, NR3C1 |
2.82848 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.81624 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.81624 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.81624 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, NR3C1, TRPV1 |
2.81167 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.79586 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.7248 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.71752 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.575 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.575 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.49391 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.46369 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.46369 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.46369 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.46369 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.32011 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22311 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.22311 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.22311 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP3A4, EGFR, ERBB2, ESR1, ESR2, ESRRB, F3, MET, MIF, NR3C1, PTPN1, SRC, TNKS2 |
2.13278 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MIF, TRPV1, TYR, XDH |
2.12559 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.11868 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TRPV1, XDH |
2.07821 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.07821 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.0576 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.0576 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP12, PIM1, PTPN1, SRC |
2.05187 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TRPV1, XDH |
2.04547 |